Added to YB: 2026-01-26
Pitch date: 2026-01-22
VIRP.PA [neutral]
Virbac SA
-9.05%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.
Market Cap
EUR 2.8B
Pitch Price
EUR 365.03
Price Target
N/A
Dividend
0.43%
EV/EBITDA
10.29
P/E
18.72
EV/Sales
2.04
Sector
Pharmaceuticals
Category
growth
Virbac (VIRP France): medium-term story intact
VIRP.PA (update): Q4 organic growth 7.1% (FY 7.9%), hitting upper end of targets despite FX headwinds. PetCare +11% constant currency, livestock mid-single digits. 2025 op margin ~16% achieved at constant currency. 2026 guidance: 5.5-7.5% growth, ~17% op margin (100bp leverage). Volume/mix driving growth vs pricing.
Read full article (2 min)